http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2330511

Outgoing Links

Predicate Object
contentType Clinical Trial|Clinical Trial, Phase I|Journal Article|Multicenter Study|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't|Research Support, U.S. Gov't, P.H.S.
endingPage 312
issn 1525-4135
issueIdentifier 3
pageRange 307-312
publicationName Journal of acquired immune deficiency syndromes (1999)
startingPage 307
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0eb2fadabf1dffb4d70280b760adba
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_aeb4cc55bd4b06b1bfef8b3991cbbf43
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8c883fba2b4c543aa93f430dadc3aea6
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4158c9390eb4d728dfe5ddbe500f6806
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_225b99e76513bd02204307c77b9ba10c
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b1adbc1a2de3b36895a086c2f0b4103a
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_35444b34dcaad547b729579451f5b942
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5a1716c7002d7e7e0db388b292ccee0d
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a71d1556b7442b6711c8adf182cc0d97
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_20091c840b6ed6c1ee3364662e050049
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_844e359196f7b9aa5c9530a6a0e1aaf4
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f2b9b6f702bcf866ee11cca310f1176d
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_29752dbb0d05537edbe87ad72904ab5b
bibliographicCitation Gerber JG, Rosenkranz SL, Fichtenbaum CJ, Vega JM, Yang A, Alston BL, Brobst SW, Segal Y, Aberg JA; AIDS Clinical Trials Group A5108 Team. Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study. J Acquir Immune Defic Syndr. 2005 Jul 01;39(3):307–12. doi: 10.1097/01.qai.0000167156.44980.33. PMID: 15980690.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b03137ab6120fd6d56c261c1c0d4dd7a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5c996986b3f85b83b89f0fae12123b8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b28937d05790b1d9c0b745f8f1be3b4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cc869495181771ccb8dc0a446dc7452
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5cf5cdce4b069006bc99d732f1bca425
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8ec935d54f7a9ac3b6b7d106293c40d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7fee281e36bb07ebe2c003de5885d292
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43020455ffbc9a30a17435d440212049
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea9364edf1920a3c6f49b2a800e32cb1
date 2005-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1097/01.qai.0000167156.44980.33
https://pubmed.ncbi.nlm.nih.gov/15980690
isPartOf https://portal.issn.org/resource/ISSN/1525-4135
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21821
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study
discusses http://id.nlm.nih.gov/mesh/M0000724
http://id.nlm.nih.gov/mesh/M0010246
http://id.nlm.nih.gov/mesh/M0005491
http://id.nlm.nih.gov/mesh/M0025879
http://id.nlm.nih.gov/mesh/M0461882
http://id.nlm.nih.gov/mesh/M0029425
http://id.nlm.nih.gov/mesh/M0018276
http://id.nlm.nih.gov/mesh/M0258297
http://id.nlm.nih.gov/mesh/M0179294
http://id.nlm.nih.gov/mesh/M0015639
http://id.nlm.nih.gov/mesh/M0028839
http://id.nlm.nih.gov/mesh/M0012591
http://id.nlm.nih.gov/mesh/M0028567
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D011758Q000493
http://id.nlm.nih.gov/mesh/D010078Q000009
http://id.nlm.nih.gov/mesh/D010078Q000008
http://id.nlm.nih.gov/mesh/D011758Q000008
http://id.nlm.nih.gov/mesh/D019380Q000009
http://id.nlm.nih.gov/mesh/D006538Q000493
http://id.nlm.nih.gov/mesh/D006949Q000209
http://id.nlm.nih.gov/mesh/D019161Q000493
http://id.nlm.nih.gov/mesh/D017035Q000493
http://id.nlm.nih.gov/mesh/D019161Q000008
http://id.nlm.nih.gov/mesh/D006538Q000008
http://id.nlm.nih.gov/mesh/D019821Q000008
http://id.nlm.nih.gov/mesh/D019821Q000493
http://id.nlm.nih.gov/mesh/D017035Q000008
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000069059
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D006949Q000378
http://id.nlm.nih.gov/mesh/D015658Q000378
http://id.nlm.nih.gov/mesh/D006949Q000188
http://id.nlm.nih.gov/mesh/D003521
http://id.nlm.nih.gov/mesh/D018023
http://id.nlm.nih.gov/mesh/D008078Q000097
http://id.nlm.nih.gov/mesh/D004347
http://id.nlm.nih.gov/mesh/D015658Q000188
http://id.nlm.nih.gov/mesh/D000480
http://id.nlm.nih.gov/mesh/D048588
http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54687
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2796
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8078
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6780
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c25c5bef0fa0efbec10a882f149a99d6
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60823
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3d4216466641a66ae41510cb235ba416
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.14.14.1

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129722732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129200050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129742546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128121087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129317935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128407104
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788925

Total number of triples: 100.